Status: Open Not Enrolling
Investigator: Anaum Maqsood
Study Coordinator: Tanya Khan
Phone: 346.238.5655
To evaluate the overall survival of HLA-A*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investigator's Choice of dacarbazine, ipilimumab, or pembrolizumab. ... Read more >
Status: Enrolling
Investigator: Nestor Esnaola
Study Coordinator: Tanya Khan
Phone: 346.238.5655
The purpose of this research study is to see whether using atezolizumab before surgery is safe and does not cause side effects that delay surgery in participants with cutaneous melanoma that has not spread to other areas of the body (non-metasta ... Read more >
Status: Open Not Enrolling
Investigator: Eric Bernicker
Study Coordinator: Tanya Khan
Phone: 346.238.5655
The purpose of this Phase Ib study is to test the safety of NG-monomethyl-L-arginine (L-NMMA) and pembrolizumab when used together in participants with melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), ... Read more >